Nicole Keeter, MSHS, PA-C, describes how to implement various JAK inhibitors into practice for the treatment of atopic dermatitis, psoriasis, and alopecia areata. She discusses how utilizing these JAK inhibitors in the treatment of atopic dermatitis has shown to provide a rapid decrease in symptoms, particularly pruritus.
After reviewing notable safety considerations for systemic and topical Janus kinase inhibitors for patients with atopic dermatitis, Nicole Keeter, PA-C, describes steps she has taken to become more comfortable prescribing these agents to her patients with AD and discusses important tips for counseling these patients on adverse events and black box warnings.
Douglas DiRuggiero, DMSc, PA-C, discusses the exciting renaissance occurring in the realm of topical treatments for atopic dermatitis.
Douglas DiRuggiero, DMSc, PA-C, discusses the mechanism of action and efficacy of topical and systemic JAK inhibitors for the treatment of atopic dermatitis.
J Clin Aesthet Dermatol. 2023;16(9 Suppl 2):S17–S18 by Kasey D’Amato PA-C, MPAP, Katie Plessinger, PA-C, and Danielle Spatholt, PA-C Ms.
J Clin Aesthet Dermatol. 2023;16(9 Suppl 2):S20–S21 by Archana M. Sangha, MMS, PA-C Ms. Sangha is a medical science liaison
J Clin Aestet Dermatol 2023;16(9 Suppl 2):S28–S31 by Michele Rutkowski, APrN, FNP-C, and Kristy Rutkowski, OTR/L Ms. M. Rutkowski is
J Clin Aesthet Dermatol. 2023;16(9 Suppl 2):S41 by Margaret A. Bobonich, DNP, FNP-C, DCNP, FAANP Dr. Bobonich is Assistant Professor
J Clin Aesthet Dermatol. 2023;16(9 Suppl 2):S42–S44 by Maria R. Robinson, MD, MBA, FAAD Dr. Robinson is a board-certified dermatologist
Reprinted with permission. Adv Ther. 2023;40:3381–3394* by Alessia Villani, Massimiliano Scalvenzi, Giuseppe Micali, Francesco Lacarrubba, Luigi Fornaro, Fabrizio Martora, Luca Potestio Authors
J Clin Aesthet Dermatol. 2023;16(6 Suppl 1):S10–S12 by Shivali Devjani, MS; Brandon Smith, BA; George Han, MD, PhD; and Jashin